- Home
- AGEN vs ESP Comparison
AGEN vs ESP Comparison
Compare AGEN & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- ESP
- Stock Information
- Founded
- AGEN 1994
- ESP 1928
- Country
- AGEN United States
- ESP United States
- Employees
- AGEN 316
- ESP N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- ESP Industrial Machinery/Components
- Sector
- AGEN Health Care
- ESP Technology
- Exchange
- AGEN Nasdaq
- ESP Nasdaq
- Market Cap
- AGEN 38.1M
- ESP 84.1M
- IPO Year
- AGEN 2000
- ESP N/A
- Fundamental
- Price
- AGEN $1.61
- ESP $27.67
- Analyst Decision
- AGEN Buy
- ESP
- Analyst Count
- AGEN 4
- ESP 0
- Target Price
- AGEN $8.00
- ESP N/A
- AVG Volume (30 Days)
- AGEN 484.8K
- ESP 13.3K
- Earning Date
- AGEN 03-11-2025
- ESP 05-12-2025
- Dividend Yield
- AGEN N/A
- ESP 3.61%
- EPS Growth
- AGEN N/A
- ESP 31.14
- EPS
- AGEN N/A
- ESP 2.45
- Revenue
- AGEN $103,463,000.00
- ESP $43,917,522.00
- Revenue This Year
- AGEN $32.21
- ESP N/A
- Revenue Next Year
- AGEN N/A
- ESP N/A
- P/E Ratio
- AGEN N/A
- ESP $11.06
- Revenue Growth
- AGEN N/A
- ESP 18.62
- 52 Week Low
- AGEN $1.44
- ESP $20.20
- 52 Week High
- AGEN $19.69
- ESP $33.00
- Technical
- Relative Strength Index (RSI)
- AGEN 21.45
- ESP 52.04
- Support Level
- AGEN $1.44
- ESP $26.50
- Resistance Level
- AGEN $1.77
- ESP $27.75
- Average True Range (ATR)
- AGEN 0.13
- ESP 0.56
- MACD
- AGEN 0.02
- ESP 0.14
- Stochastic Oscillator
- AGEN 8.00
- ESP 65.97
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.